Infographic: What could you buy with the $20.5 trillion Elizabeth Warren’s health plan calls for in new federal spending?
That number got many of us at MM&M thinking: What else can be bought with $20,500,000,000,000?
Regulatory
Open enrollment on pace amid ACA uncertainty
The healthcare law is facing court challenges, but enrollment is chugging on.
Policy Outlook 2020: Expect loads of talk, little action around biggest healthcare issues
A presidential election in 2020 means candidates and surrogates will be talking about healthcare, but the chances of meaningful change are slim.
Lawsuits against Juul echo opioid cases
New York and California have sued the e-cigarette company for deceptive marketing that contributed to a public health crisis.
It’s back! Bill requiring list prices in DTC ads resurfaces
Sens. Chuck Grassley and Dick Durbin hoped to pass the bill through unanimous consent last week, ahead of impeachment proceedings and a budget battle.
It’s time to push back on drug price legislation
Sander Flaum wants pharma to push back on pricing legislation.
Patterns emerge as vaping-related lung illnesses continue to rise
As more patients fall ill from the vaping lung illness, health officials are piecing together a more complete picture of the outbreak.
GOP, Dems agree on international reference price policy, but the devil is in the details
International reference pricing for drugs is great in theory, but Dems and the GOP are at odds over the details in each plan.
Report: Stephen Hahn to be nominated as FDA head, Brett Giroir as acting chief
Dr. Stephen Hahn emerged as the frontrunner to lead the FDA in recent months.
FDA’s first ‘modified risk’ tobacco products set precedent
They could set the standard for vaping products.
Want to read more?
Please login or register first to view this content.
